“…(R,Z)-N-(2-(Dimethylphenylsilyl)-3-phenylallyl)-2-methylpropane-2-sulfinamide (3fa):GP [from 1f (123.4 mg, 0.52 mmol) with PhMe2SiLi 2a (1.5 M in THF, 1.5 mL, 2.34 mmol, 4.5 equiv), column chromatography with an eluent (CH2Cl2/EtOAc = 1/1)] afforded 3fa as a colorless oil (171.0 mg, 0.460 mmol, 89%). [α] 20 D 19.6 (c 1.00, CHCl3); 1 H NMR (600 MHz, CDCl3): δ 7.50 (s, 1H), 7.47 (m, 2H), 7.33-7.29 (m, 3H), 7.20-7.18 (m, 3H), 7.14-7.12 (m, 2H), 4.00 (dd, J = 13.7, 3.4 Hz, 1H), 3.88 (ddd, J = 13.7, 8.9, 1.4 Hz, 1H), 3.19 (m, 1H), 1.18 (s, 9H), 0.22 (s, 3H), 0.16 (s, 3H);13 C NMR (151 MHz, CDCl3): δ 146.0, 139.1, 139.0, 138.5, 133.9, 129.0, 128.6, 127.91, 127.86, 127.4, 55.9, 53.4, 22.8, -1.18, -1.20; HRMS (APCI-MS, positive) m/z [M+H] + calcd for C21H30NOSSi: 372.1812; found: 372.1824. (Z)-N-(2-(Dimethylphenylsilyl)-3-phenylallyl)benzenesulfonamide (3ga):GP [from 1g (271.1 mg, 0.950 mmol) with PhMe2SiLi 2a (1.5 M in THF, 2.2 mL, 3.33 mmol, 3.5 equiv), column chromatography with an eluent (CH2Cl2 only)] afforded 3ga as a pale yellow oil (328.9 mg, 0.807 mmol, 85%).…”